Catalog No.
YVV31402
Expression system
E. coli
Species
Zika virus (isolate ZIKV/Human/French Polynesia/10087PF/2013) (ZIKV)
Protein length
Arg589-Ile697
Predicted molecular weight
14.09 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
A0A024B7W1
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Genome polyprotein, Envelope protein E
Structural basis for antibody cross-neutralization of dengue and Zika viruses., PMID:40502094
Purification, refolding, and pH-dependent stability evaluation of Zika virus EDIII protein., PMID:40478414
Antiviral in vitro activity of a novel dichlorinated tyrosine methyl ester derivative against the infection of two flaviviruses of public health concern, dengue and zika virus., PMID:40450991
From Antibodies to Immunity: Assessing Correlates of Flavivirus Protection and Cross-Reactivity., PMID:40432061
Serologic Surveillance for Orthoflaviviruses and Chikungunya Virus in Bats and Opossums in Chiapas, Mexico., PMID:40431603
A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage., PMID:40425591
Autophagy-mediated downregulation of AXL and TIM-1 promotes sustained Zika virus infection., PMID:40408405
Seroprevalence and Placental Transfer of Zika and Dengue Virus Antibodies in Postpartum Women in Southeast Brazil., PMID:40400258
A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses., PMID:40364846
Heterologous prime-boost Zika virus vaccination induces comprehensive humoral and cellular immunity in mouse models., PMID:40352923
Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease., PMID:40333188
Targeting immunogenic proteins of Zika virus for the prediction of immunoinformatics-driven circular mRNA vaccine model., PMID:40291442
Multi-omics analysis reveals key immunogenic signatures induced by oncolytic Zika virus infection of paediatric brain tumour cells., PMID:40240536
Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881
Immunogenicity of a single dose of the 17DD yellow fever vaccine in a cohort of adults and children in a non-endemic area, and its association with dengue and Zika seropositivity., PMID:40202994
Anellovirus abundance as an indicator for viral metagenomic classifier utility in plasma samples., PMID:40148934
Genome-Wide Analysis of Stable RNA Secondary Structures across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics., PMID:40131856
Altered Cellular Pathways in the Blood of Patients With Guillain-Barre Syndrome., PMID:40099626
Identification of B-cell epitopes of Indian Zika virus strains using immunoinformatics., PMID:40083545
Caspase-1/11 controls Zika virus replication in astrocytes by inhibiting glycolytic metabolism., PMID:40070207
High correlation between detection of dengue IgG from dried blood spots and serum using an indirect IgG ELISA assay: A validation study in Fortaleza, Brazil., PMID:40019871
Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865
Virus-like particle vaccine with authentic quaternary epitopes protects against Zika virus-induced viremia and testicular damage., PMID:40013767
Critical parameters on Zika virus-like particles' generation., PMID:39978420
Dual roles of exostosin glycosyltransferase 1 in Zika virus infection., PMID:39927690
Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches., PMID:39905499
Dual surrogate imprinting: an innovative strategy for the preparation of virus-selective particles., PMID:39846824
A Lambda-evo (λevo) phage platform for Zika virus EDIII protein display., PMID:39820667
Autophagy-Mediated Downregulation of AXL and TIM-1 Promotes Sustained Zika Virus Infection., PMID:39803534
Serologic and Molecular Evidence of Arboviruses in Nonhuman Primates in Northeast Brazil., PMID:39799547
Comparison of Three Chimeric Zika Vaccine Prototypes Developed on the Genetic Background of the Clinically Proven Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2., PMID:39796052
Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis., PMID:39789283
Ubiquitin-like modifier-activating enzyme 1 interacts with Zika virus NS5 and promotes viral replication in the infected cell., PMID:39773572
Cardiac Biomarkers in a Brazilian Indigenous Population Exposed to Arboviruses: A Cross-Sectional Study., PMID:39772209
A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses., PMID:39764453
ITGB4/CD104 mediates zika virus attachment and infection., PMID:39737945
Identification and Evaluation of Natural Compounds as Potential Inhibitors of NS2B-NS3 Zika Virus Protease: A Computational Approach., PMID:39733219
Designing of new trans-stilbene derivative: An entry barrier of Zika virus in host cell., PMID:39731815
High glucose potentiates Zika virus induced-astroglial dysfunctions., PMID:39625558
Serotype-Specific Dengue Virus IgG Assay Using EDIII-Based Recombinant Proteins and Its Application in an Endemic Population in Northeast Brazil., PMID:39620308
Analysis of the heterologous expression, localization, and cellular response to the Zika virus E protein in vitro., PMID:39605121
Analysis of Memory Antibody Responses in Individuals with Zika-Associated Guillain-Barré Syndrome., PMID:39599819
An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice., PMID:39588106
Immunogenicity and protection of a triple repeat domain III mRNA vaccine against Zika virus., PMID:39547049
Protective threshold of a potent neutralizing Zika virus monoclonal antibody in rhesus macaques., PMID:39545728
Membrane fusion by dengue virus: The first step., PMID:39522596
Preparation and Construction of Chimeric Humanized Broadly Reactive Antibody 10H10 to Protein E of Tick-Borne Encephalitis Virus., PMID:39441444
Envelope Protein in Differential Serodiagnosis of Dengue, Zika and Chikungunya Viruses: A Systematic Review., PMID:39428933
Genome-Wide Identification of Stable RNA Secondary Structures Across Multiple Organisms Using Chemical Probing Data: Insights into Short Structural Motifs and RNA-Targeting Therapeutics., PMID:39416040
A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice., PMID:39414822
For research use only. Not for human or drug use.
